Generic Drug Entry

The establishment of comprehensive labeling standards for generic drugs is critical to ensuring patient safety, regulatory compliance, and market integrity.

Bioequivalence requirements for generics are essential standards ensuring that approved generic medicines match their brand-name counterparts in safety and efficacy.

The Abbreviated New Drug Application (ANDA) process is fundamental to the entry of generic drugs into the market, impacting both

The regulatory pathway for generic drugs is a crucial component in ensuring affordable and timely access to vital medications globally.